BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3093094)

  • 1. 402AX teratocarcinoma MHC class I antigen expression is regulated in vivo by Lyt 1, Lyt 2, and L3T4 expressing splenic T cells.
    Ostrand-Rosenberg S; Clements V; Marr L
    Cell Immunol; 1986 Apr; 98(2):257-65. PubMed ID: 3093094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to 402AX teratocarcinoma involves immunity to minor histocompatibility antigens.
    Ostrand-Rosenberg S; Clements V
    Immunogenetics; 1987; 26(1-2):1-5. PubMed ID: 3301646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of major histocompatibility gene expression in teratocarcinoma 402AX cells.
    Ostrand-Rosenberg S; Clements V; Cole G; DeCloux A; Marr L; Schwartzman M
    Cell Differ; 1984 Dec; 15(2-4):221-7. PubMed ID: 6336034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple splenic lymphoid cell subpopulations regulate H-2 antigen expression on teratocarcinoma cells in vivo.
    Ostrand-Rosenberg S; Cohn AL; Sandoz JW
    J Immunol; 1983 Jun; 130(6):2969-73. PubMed ID: 6133895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfection and expression of syngeneic H-2 genes does not reduce malignancy of H-2 negative teratocarcinoma cells in the autologous host.
    Ostrand-Rosenberg S; Cole GA; Nishimura MI; Clements VK
    Cell Immunol; 1990 Jun; 128(1):152-64. PubMed ID: 2344619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teratocarcinoma cell MHC antigen expression is regulated in vitro by a soluble noninterferon factor.
    Ostrand-Rosenberg S; Schwartzman ML; Hecht TT; Marr L
    Cell Immunol; 1986 May; 99(2):453-60. PubMed ID: 3093106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of antibodies to Lyt-2 and L3T4 on cytolysis by cloned, Ia-restricted T cells expressing both proteins.
    Jones B; Khavari PA; Conrad PJ; Janeway CA
    J Immunol; 1987 Jul; 139(2):380-4. PubMed ID: 3110269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface markers of T cells causing lethal graft-vs-host disease to class I vs class II H-2 differences.
    Korngold R; Sprent J
    J Immunol; 1985 Nov; 135(5):3004-10. PubMed ID: 3876371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of the Lyt-2-,L3T4+ lineage of T cells in mice treated neonatally with anti-I-A correlates with absence of intrathymic I-A-bearing antigen-presenting cell function.
    Kruisbeek AM; Mond JJ; Fowlkes BJ; Carmen JA; Bridges S; Longo DL
    J Exp Med; 1985 May; 161(5):1029-47. PubMed ID: 3921649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H-2 antigen expression on teratocarcinoma cells passaged in genetically resistant mice is regulated by lymphoid cells.
    Ostrand-Rosenberg S; Cohn A
    Proc Natl Acad Sci U S A; 1981 Nov; 78(11):7106-10. PubMed ID: 7031669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L3T4-positive T cells participate in the induction of graft-vs-host disease in response to minor histocompatibility antigens.
    Hamilton BL
    J Immunol; 1987 Oct; 139(8):2511-5. PubMed ID: 3498761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency analysis of class I MHC-reactive Lyt-2+ and class II MHC-reactive L3T4+ IL 2-secreting T lymphocytes.
    Heeg K; Steeg C; Schmitt J; Wagner H
    J Immunol; 1987 Jun; 138(12):4121-7. PubMed ID: 3108383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal analysis of murine graft-vs-host disease. I. Phenotypic and functional analysis of T lymphocyte clones.
    Parkman R
    J Immunol; 1986 May; 136(10):3543-8. PubMed ID: 2871104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of Lyt-2 and L3T4 in activation of hapten-specific Lyt-2+ L3T4+ T-cell clones.
    Fazekas de St Groth B; Gallagher PF; Miller JF
    Proc Natl Acad Sci U S A; 1986 Apr; 83(8):2594-8. PubMed ID: 3085100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfection of major histocompatibility complex class I and class II genes causes tumour rejection.
    Ostrand-Rosenberg S; Clements VK; Thakur A; Cole GA
    J Immunogenet; 1989; 16(4-5):343-9. PubMed ID: 2639907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular interactions and the role of interleukin 2 in the expression and induction of immunity against a syngeneic murine sarcoma.
    Chou T; Shu S
    J Immunol; 1987 Sep; 139(6):2103-9. PubMed ID: 2957448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell clones with L3T4-positive or Lyt-2-positive phenotypes responding to mutant MHC class II antigen and inducing graft versus host reaction.
    Watanabe H; Fujiwara M; Mashiko T; Ito M
    J Invest Dermatol; 1989 Nov; 93(5):691-4. PubMed ID: 2571645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from a syngeneic murine sarcoma.
    Ward BA; Shu S; Chou T; Perry-Lalley D; Chang AE
    J Immunol; 1988 Aug; 141(3):1047-53. PubMed ID: 3260908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective activation of resting mouse T lymphocytes by cross-linking submitogenic concentrations of the T cell antigen receptor with either Lyt-2 or L3T4.
    Eichmann K; Jönsson JI; Falk I; Emmrich F
    Eur J Immunol; 1987 May; 17(5):643-50. PubMed ID: 3108015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of two distinct primary T cell populations that secrete interleukin 2 upon recognition of class I or class II major histocompatibility antigens.
    Mizuochi T; Ono S; Malek TR; Singer A
    J Exp Med; 1986 Mar; 163(3):603-19. PubMed ID: 2936862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.